You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

deferasirox

Showing 1 - 25 of 114
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thalassemia Major Trial in New York, Bangkok, Chiang Mai (DST-0509, Jadenu, Exjade)

Completed
  • Thalassemia Major
  • New York, New York
  • +3 more
Jan 31, 2022

Transfusion-dependent Thalassemia, Non-transfusion-dependent Thalassemia Trial in Worldwide (Deferasirox dispersable tablet

Completed
Has Results
  • Transfusion-dependent Thalassemia
  • Non-transfusion-dependent Thalassemia
  • Deferasirox dispersable tablet (DT)
  • Deferasirox film coated tablet (FCT)
  • Alexandria, Egypt
  • +16 more
Sep 6, 2021

Measures to Prevent Liver and Pancreas Complications in

Active, not recruiting
  • Iron Overload
  • Deferasirox
  • Trieste, Italy
    IRCCS Burlo Garofolo
Jan 4, 2022

Thalassemia, Iron Overload Trial in Oakland (Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO))

Completed
Has Results
  • Thalassemia
  • Iron Overload
  • Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)
  • Oakland, California
    CHRCO
Jul 20, 2021

Sickle Cell Disease Trial in Amsterdam (Deferasirox 360 MG)

Recruiting
  • Sickle Cell Disease
  • Deferasirox 360 MG
  • Amsterdam, Meibergdreef 9, Netherlands
    Amsterdan UMC location AMC
May 23, 2022

Cardiac Iron Overload Trial in Worldwide (Deferasirox and Deferoxamine)

Completed
Has Results
  • Cardiac Iron Overload
  • Deferasirox and Deferoxamine
  • Toronto, Ontario, Canada
  • +14 more
Jul 23, 2021

Beta-thalassemia, Iron Overload Trial in Los Angeles, Oakland, Chicago (Deferasirox)

Completed
Has Results
  • Beta-thalassemia
  • Iron Overload
  • Deferasirox
  • Los Angeles, California
  • +2 more
Jun 8, 2021

MDS, Iron Overload Trial in Stanford, Detroit, Houston (Deferasirox)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Iron Overload
  • Deferasirox
  • Stanford, California
  • +2 more
Jun 1, 2021

Transfusional Iron Overload, Iron Overload, Iron Chelation Trial (SPD602, Deferasirox)

Withdrawn
  • Transfusional Iron Overload
  • +6 more
  • (no location specified)
Jun 1, 2021

Hepatic Impairment Trial in Kiel (Deferasirox)

Completed
  • Hepatic Impairment
  • Deferasirox
  • Kiel, Germany
    Novartis Investigative Site
Dec 6, 2020

ß-thalassemia, Transfusional Iron Overload Trial in Cagliari, Genova, Orbassano (Deferasirox)

Completed
  • β-thalassemia
  • Transfusional Iron Overload
  • Deferasirox
  • Cagliari, CA, Italy
  • +2 more
Dec 6, 2020

MDS Trial in Erlangen (Deferasirox (Novartis Pharma))

Terminated
Has Results
  • Myelodysplastic Syndromes
  • Deferasirox (Novartis Pharma)
  • Erlangen, Bavaria, Germany
    Medizinische Klinik 5, Universitätsklinikum Erlangen
Sep 11, 2020

Chronic Iron Overload Trial in Worldwide (Deferiprone, Deferasirox)

Completed
Has Results
  • Chronic Iron Overload
  • Lushnjë, Albania
  • +21 more
Apr 8, 2021

Endocrine Function During Deferasirox Therapy

Completed
  • Iron Overload
  • +2 more
    • Naples, Italy
      Università degli Studi della Campania Luigi Vanvitelli
    Aug 13, 2020

    Anemia, Myelodysplastic Syndrome Trial in Seattle (Deferasirox, Laboratory Biomarker Analysis)

    Terminated
    Has Results
    • Anemia
    • Myelodysplastic Syndrome
    • Deferasirox
    • Laboratory Biomarker Analysis
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jun 12, 2020

    Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)

    Completed
    Has Results
    • Myelodysplastic Syndrome
    • Iron Overload
    • Deferasirox
    • Birmingham, Alabama
    • +47 more
    Jul 21, 2021

    High Risk MDS or AML Patients Trial in Philadelphia (Exjade® (deferasirox, ICL670))

    Completed
    • High Risk MDS or AML Patients
    • Exjade® (deferasirox, ICL670)
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Apr 7, 2020

    Acute Myeloid Leukemia Trial in Maywood (Deferasirox, Cholecalciferol, Azacitidine)

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • Deferasirox
    • +2 more
    • Maywood, Illinois
      Loyola University Cardinal Bernardin Cancer Center
    Feb 25, 2020

    Chronic Iron Overload Trial in Austria, Greece, Italy (Deferasirox)

    Completed
    Has Results
    • Chronic Iron Overload
    • Deferasirox
    • Vienna, Austria
    • +13 more
    Feb 18, 2020

    Transfusion-dependent ß-thalassemia Patients, Cardiac Iron Overload Trial in Athens, Patras (Deferasirox, Deferoxamine (DFO))

    Terminated
    Has Results
    • Transfusion-dependent β-thalassemia Patients
    • Cardiac Iron Overload
    • Deferasirox
    • Deferoxamine (DFO)
    • Athens, GR, Greece
    • +3 more
    Oct 21, 2019

    Non-transfusion Dependent Thalassemia Trial in Worldwide (deferasirox)

    Completed
    Has Results
    • Non-transfusion Dependent Thalassemia
    • deferasirox
    • Nanning, Guangxi, China
    • +10 more
    Sep 19, 2019

    Transfusion-dependent Hemachromatosis, Thalassemia Major, Sickle Cell Disease Trial in Boston (Deferoxamine, Deferasirox, HIDA)

    Completed
    Has Results
    • Transfusion-dependent Hemachromatosis
    • +2 more
    • Boston, Massachusetts
      Children's Hospital Boston
    Jun 14, 2019

    MDS Trial in Worldwide (Deferasirox, Placebo)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Deferasirox
    • Placebo
    • Anaheim, California
    • +71 more
    Oct 30, 2020

    MDS Trial in Italy (Deferasirox)

    Unknown status
    • Myelodysplastic Syndromes
    • Deferasirox
    • Firenze, FI, Italy
    • +9 more
    Jul 15, 2019

    Thalassemia Major With Severe Transfusional Iron Overload Trial in Chicago, Philadelphia (Deferasirox and deferiprone)

    Completed
    Has Results
    • Thalassemia Major With Severe Transfusional Iron Overload
    • Deferasirox and deferiprone
    • Chicago, Illinois
    • +1 more
    Feb 13, 2019